Bits of technology from I.B.M.’s Watson are beginning to be used in actual products available to corporate clients. The cloud-based Strategic Intellectual Property Insight Platform “uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical journals to look for chemical compounds used in drug discovery.” As a byproduct of this project, I.B.M. is contributing their research to the searchable NIH chemical database, which will ease access to information previously mired in paperwork.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
TagsBIOTECH biofuels Plant biotechnology biotechnology BIO International Convention health BIO EVENT climate change Health Care agriculture healthcare BIO Events business development Biotechnology Industry Food Sustainability biotech industry Intellectual Property Benefits of biotech crops GMOs
- Most Popular
Latest Videohttps://youtube.com/devicesupport View All >